Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia

European Neuropsychopharmacology

Volumn 18, Issue 9, 2008, Pages 667-672

  Poyraz, Burç Ç ^a   Aksoy, Cana ^a   Balcioǧlu, Ibrahim ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Antipsychotic; Autoimmune thyroiditis; Autoimmunity; Hyperprolactinemia; Immune system; Schizophrenia

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PROLACTIN; QUETIAPINE; RISPERIDONE; SULPIRIDE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; AUTOIMMUNE THYROIDITIS; CHRONIC DRUG ADMINISTRATION; FEMALE; FREE THYROXINE INDEX; HUMAN; HYPERPROLACTINEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; AUTOANTIBODIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPROLACTINEMIA; INCIDENCE; MALE; MIDDLE AGED; PROLACTIN; SCHIZOPHRENIA; SEX FACTORS; THYROIDITIS, AUTOIMMUNE;

EID: 48749096248     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.04.014     Document Type: Article

References (39)

1. Boin F., Zanardini R., Pioli R., Altamura C.A., Maes M., and Gennarelli M. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol. Psychiatry 6 (2001) 79-82
2. Bongu D., Sachdev J., and Kabadi U.M. Effects of carbamazepine on the hypothalamic-pituitary-thyroid axis. Endocr. Pract. 5 (1999) 239-244
3. Buskila D., Berezin M., Gur H., Lin H.C., Alosachie I., Terryberry J.W., Barka N., Shen B., Peter J.B., and Shoenfeld Y. Autoantibody profile in the sera of women with hyperprolactinemia. J. Autoimmun. 8 (1995) 415-424
4. Canoso R.T., de Oliveira R.M., and Nixon R.A. Neuroleptic-associated autoantibodies. A prevalence study. Biol. Psychiatry 27 (1990) 863-870
5. Cansu A., Serdaroǧlu A., Çamurdan O., Hi{dotless}rfanoǧlu T., Bideci A., and Gücüyener K. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Epilepsia 47 (2006) 1855-1859
6. Compton M.T., and Miller A.H. Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol. Bull. 36 (2002) 143-164
7. De Bellis A., Bizzarro A., Pivonello R., Lombardi G., and Bellastella A. Prolactin and autoimmunity. Pituitary 8 (2005) 25-30
8. Drzyzga L., Obuchowicz E., Marcinowska A., and Herman Z.S. Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain. Behav. Immun. 20 (2006) 532-545
9. Eaton W.W., Byrne M., Ewald H., Mors O., Chen C.Y., Agerbo E., and Mortensen P.B. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am. J. Psychiatry 163 (2006) 521-528
10. El-Sherif W.T., El Gendi S.S., Ashmawy M.M., Ahmed H.M., and Salama M.M. Thyroid disorders and autoantibodies in systemic lupus erythematosus and rheumatoid arthritis patients. Egypt. J. Immunol. 11 (2004) 81-90
11. Giusti M., Foppiani L., Fazzuoli L., Molinari E., Guido R., Valenti S., and Giordano G. An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs. Recenti Prog. Med. 90 (1999) 147-151
12. Jara L.J., Navarro C., Brito-Zerón Mdel P., García-Carrasco M., Escárcega R.O., and Ramos-Casals M. Thyroid disease in Sjögren's syndrome. Clin. Rheumatol. 26 (2007) 1601-1606
13. Kramer C.K., Tourinho T.F., de Castro W.P., and da Costa Oliveira M. Association between systemic lupus erythematosus, rheumatoid arthritis, hyperprolactinemia and thyroid autoantibodies. Arch. Med. Res. 36 (2005) 54-58
14. Kupka R.W., Nolen W.A., Post R.M., McElroy S.L., Altshuler L.L., Denicoff K.D., Frye M.A., Keck Jr. P.E., Leverich G.S., Rush A.J., Suppes T., Pollio C., and Drexhage H.A. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol. Psychiatry 51 (2002) 305-311
15. Laurberg P., Andersen S., Bülow Pedersen I., and Carlé A. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment. Drugs Aging 22 (2005) 23-38
16. Matera L., Mori M., Geuna M., Buttiglieri S., and Palestro G. Prolactin in autoimmunity and antitumor defence. J. Neuroimmunol. 109 (2000) 47-55
17. Mikati M.A., Tarabay H., Khalil A., Rahi A.C., El Banna D., and Najjar S. Risk factors for development of subclinical hypothyroidism during valproic acid therapy. J. Pediatr. 151 (2007) 178-181
18. Miller J., and Carney P. Central hypothyroidism with oxcarbazepine therapy. Pediatr. Neurol. 34 (2006) 242-244
19. Olive K.E., and Hennessey J.V. Marked hyperprolactinemia in subclinical hypothyroidism. Arch. Intern. Med. 148 (1988) 2278-2279
20. Othman S.S., Abdul Kadir K., Hassan J., Hong G.K., Singh B.B., and Raman N. High prevalence of thyroid function test abnormalities in chronic schizophrenia. Aust. N. Z. J. Psychiatry 28 (1994) 620-624
21. Overall J.E., and Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 10 (1962) 799-812
22. Pollmächer T., Haack M., Schuld A., Kraus T., and Hinze-Selch D. Effects of antipsychotic drugs on cytokine networks. J. Psychiatr. Res. 34 (2000) 369-382
23. Prummel M.F., and Wiersinga W.M. Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005) 1-15
24. Prummel M.F., Strieder T., and Wiersinga W.M. The environment and autoimmune thyroid diseases. Eur. J. Endocrinol. 150 (2004) 605-618
25. Raber W., Gessl A., Nowotny P., and Vierhapper H. Hyperprolactinaemia in hypothyroidism: clinical significance and impact of TSH normalization. Clin. Endocrinol. 58 (2003) 185-191
26. Rothermundt M., Arolt V., and Bayer T.A. Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 15 (2001) 319-339
27. Rumbyrt J.S., and Schocket A.L. Chronic urticaria and thyroid disease. Immunol. Allergy Clin. North Am. 24 (2004) 215-223
28. Schwarz M.J., Riedel M., Gruber R., Müller N., and Ackenheil M. Autoantibodies against 60-kDa heat shock protein in schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 248 (1998) 282-288
29. Semiz U.B., Cetin M., Basoglu C., Ebrinc S., Uzun O., Herken H., Balibey H., Algul A., and Ates A. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 1330-1336
30. Soykan, C., 1989. Institutional differences and case typicality as related to diagnosis system severity, prognosis and treatment. Unpublished Master's thesis, Middle East University, Ankara, Turkey.
31. Spivak B., Radwan M., Bartur P., Mester R., and Weizman A. Antinuclear autoantibodies in chronic schizophrenia. Acta. Psychiatr. Scand. 92 (1995) 266-269
32. Strous R.D., and Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J. Autoimmun. 27 (2006) 71-80
33. Svestka J., Synek O., Tomanová J., Rodáková I., and Cejpková A. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients. Neuro. Endocrinol. Lett. 28 (2005) 881-888
34. Uzun Ö., Cansever A., Basoǧlu C., and Özşahin A. Smoking and substance abuse in outpatients with schizophrenia: a 2-year follow-up study in Turkey. Drug Alcohol Depend. 70 (2003) 187-192
35. Vera-Lastra O., Jara L.J., and Espinoza L.R. Prolactin and autoimmunity. Autoimmun. Rev. 1 (2002) 360-364
36. Verhelst J., and Abs R. Hyperprolactinemia: pathophysiology and management. Treat. Endocrinol. 2 (2003) 23-32
37. Watanabe Y., Nakayama T., Nagakubo D., Hieshima K., Jin Z., Katou F., Hashimoto K., and Yoshie O. Dopamine selectively induces migration and homing of naive CD8+ T cells via dopamine receptor D3. J. Immunol. 176 (2006) 848-856
38. Wieck A., and Haddad P. Hyperprolactinaemia caused by antipsychotic drugs. BMJ. 324 (2002) 250-252
39. Yin J., Albert R.H., Tretiakova A.P., and Jameson B.A. 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes. J. Neuroimmunol. 181 (2006) 68-81